Obesity significantly reduced the effectiveness of febuxostat-based urate-lowering therapy among men with gout, a recent ...

The current target of gout treatment is to reduce levels down to 6 mg/dL or less. SEL-212 is based on a uricase enzyme (pegadricase) that breaks down uric acid in the blood combined with an immune ...

China: A recent prospective cohort study has revealed that obesity significantly reduces the effectiveness of ...

London’s luxury hotel spas have come into their own, offering so much more than basic massages and simple house facials.

From life-altering genetic conditions to promising new treatments, here's what you need to know about 7 inherited diseases ...

About XORTX Therapeutics Inc. XORTX is a pharmaceutical company with three clinically advanced products in development: 1) our lead, XRx-008 program for ADPKD; 2) our XRx-026 program for the treatment ...

Research analysts at Cantor Fitzgerald reduced their FY2025 earnings estimates for Amgen in a research note issued to ...

American Association of Clinical Endocrinology (AACE) guidelines offer evidence-based recommendations for the pharmacologic ...

Amgen (NASDAQ:AMGN – Get Free Report) had its target price increased by Piper Sandler from $310.00 to $329.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently ...

CDC data shows a 15% increase in stroke cases among younger Americans over the past decade, with significant rises in risk ...

Doctors have long believed that high levels of uric acid in the blood (a condition called hyperuricemia) were the main cause ...

For patients with gout who cannot get ... of SEL-212 hitting the tougher target of a uric acid level of 1.5 mg/dL or lower for 80% of month six after starting treatment. A six-month extension ...